Accendra Health, Inc. (NYSE: ACH) Stock Competitors & Peer Comparison
See ACH's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ACH and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACH | $1.24 | -6.44% | 99.9M | 1.92 | $0.68 | N/A |
| MCK | $863.20 | +1.11% | 98.2B | 20.55 | $40.82 | +0.39% |
| COR | $319.18 | +0.66% | 61.2B | 18.35 | $17.15 | +0.76% |
| CAH | $228.91 | -2.53% | 53.5B | 21.90 | $10.43 | +0.89% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $88.47 | -0.92% | 10.1B | 16.66 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| PBH | $50.93 | -1.45% | 2.4B | 11.43 | $4.42 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| HX | $2.24 | -4.27% | 53.4M | -1.84 | -$1.22 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
ACH vs MCK Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, MCK has a market cap of 98.2B. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while MCK trades at $863.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas MCK's P/E ratio is 20.55. In terms of profitability, ACH's ROE is +0.63%, compared to MCK's ROE of -1.94%. Regarding short-term risk, ACH is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for ACH.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
ACH vs COR Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, COR has a market cap of 61.2B. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while COR trades at $319.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas COR's P/E ratio is 18.35. In terms of profitability, ACH's ROE is +0.63%, compared to COR's ROE of +1.06%. Regarding short-term risk, ACH is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for ACH.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
ACH vs CAH Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, CAH has a market cap of 53.5B. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while CAH trades at $228.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas CAH's P/E ratio is 21.90. In terms of profitability, ACH's ROE is +0.63%, compared to CAH's ROE of -0.60%. Regarding short-term risk, ACH is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for ACH.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
ACH vs ABC Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas ABC's P/E ratio is 21.92. In terms of profitability, ACH's ROE is +0.63%, compared to ABC's ROE of +1.06%. Regarding short-term risk, ACH is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for ACH.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
ACH vs HSIC Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, HSIC has a market cap of 10.1B. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while HSIC trades at $88.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas HSIC's P/E ratio is 16.66. In terms of profitability, ACH's ROE is +0.63%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, ACH is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for ACH.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
ACH vs PDCO Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas PDCO's P/E ratio is 20.48. In terms of profitability, ACH's ROE is +0.63%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, ACH is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for ACH.Check PDCO's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
ACH vs PBH Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while PBH trades at $50.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas PBH's P/E ratio is 11.43. In terms of profitability, ACH's ROE is +0.63%, compared to PBH's ROE of +0.09%. Regarding short-term risk, ACH is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for ACH.Check PBH's competition here
Owens & Minor, Inc. (NYSE: OMI)
ACH vs OMI Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas OMI's P/E ratio is -0.47. In terms of profitability, ACH's ROE is +0.63%, compared to OMI's ROE of +0.63%. Regarding short-term risk, ACH is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for ACH.Check OMI's competition here
Akso Health Group (NASDAQ: HX)
ACH vs HX Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas HX's P/E ratio is -1.84. In terms of profitability, ACH's ROE is +0.63%, compared to HX's ROE of -1.07%. Regarding short-term risk, ACH is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for ACH.Check HX's competition here
111, Inc. (NASDAQ: YI)
ACH vs YI Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, YI has a market cap of 29.8M. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while YI trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas YI's P/E ratio is -2.44. In terms of profitability, ACH's ROE is +0.63%, compared to YI's ROE of +0.14%. Regarding short-term risk, ACH is more volatile compared to YI. This indicates higher risk in terms of short-term price fluctuations for ACH.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
ACH vs WGRX Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas WGRX's P/E ratio is -0.33. In terms of profitability, ACH's ROE is +0.63%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, ACH is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for ACH.Check WGRX's competition here
ZeroStack Corp. (NASDAQ: ZSTK)
ACH vs ZSTK Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, ZSTK has a market cap of 6.2M. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while ZSTK trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas ZSTK's P/E ratio is -0.12. In terms of profitability, ACH's ROE is +0.63%, compared to ZSTK's ROE of -3.82%. Regarding short-term risk, ACH is less volatile compared to ZSTK. This indicates lower risk in terms of short-term price fluctuations for ACH.Check ZSTK's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
ACH vs MEDS Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, MEDS has a market cap of 3.8M. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while MEDS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas MEDS's P/E ratio is N/A. In terms of profitability, ACH's ROE is +0.63%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, ACH is more volatile compared to MEDS. This indicates higher risk in terms of short-term price fluctuations for ACH.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
ACH vs ZYXI Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, ACH's ROE is +0.63%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, ACH is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for ACH.Check ZYXI's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
ACH vs SNYR Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, SNYR has a market cap of 1.2M. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while SNYR trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas SNYR's P/E ratio is -0.08. In terms of profitability, ACH's ROE is +0.63%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, ACH is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for ACH.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
ACH vs RDGT Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, RDGT has a market cap of 724.3K. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while RDGT trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas RDGT's P/E ratio is -0.01. In terms of profitability, ACH's ROE is +0.63%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, ACH is more volatile compared to RDGT. This indicates higher risk in terms of short-term price fluctuations for ACH.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
ACH vs CVET Comparison August 2026
Accendra Health, Inc. (NYSE: ACH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACH stands at 99.9M. In comparison, CVET has a market cap of 0. Regarding current trading prices, ACH is priced at $1.24 on the NYSE, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACH currently has a P/E ratio of 1.92, whereas CVET's P/E ratio is -69.97. In terms of profitability, ACH's ROE is +0.63%, compared to CVET's ROE of -0.06%. Regarding short-term risk, ACH is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for ACH.Check CVET's competition here